Clinical TrialsAstellas Ignites a New Front in KRAS G12D Battle with Phase 3 Entry of Seti... Astellas Ignites a New Front in KRAS G12D Battle with Phase 3 Entry of Seti... Read Post »
Clinical TrialsINGREZZA Secures the Long Game as AUSTEDO XR Lags in Treatment Persistence INGREZZA Secures the Long Game as AUSTEDO XR Lags in Treatment Persistence Read Post »
Clinical TrialsAligos Maps a Wider HBV Horizon as Pevifoscorvir Gains Ground in Phase 2 Aligos Maps a Wider HBV Horizon as Pevifoscorvir Gains Ground in Phase 2 Read Post »
Clinical TrialsDaraxonrasib Ignites a Survival Breakthrough in Pancreatic Cancer’s Tough... Daraxonrasib Ignites a Survival Breakthrough in Pancreatic Cancer’s Tough... Read Post »
Clinical TrialsSpyre’s SPY001 Pushes the Boundary of UC Care with Promising Induction Re... Spyre’s SPY001 Pushes the Boundary of UC Care with Promising Induction Re... Read Post »
Clinical TrialsIDEAYA and Servier Anchor Darovasertib Combo in Metastatic Uveal Melanoma IDEAYA and Servier Anchor Darovasertib Combo in Metastatic Uveal Melanoma Read Post »
Clinical TrialsEmactuzumab Breaks the Cycle of Chronic Therapy in TGCT with Phase 3 Result... Emactuzumab Breaks the Cycle of Chronic Therapy in TGCT with Phase 3 Result... Read Post »
Clinical TrialsAllogene Brings CAR T to the Frontline Edge, ALPHA3 Shows Early MRD Win Allogene Brings CAR T to the Frontline Edge, ALPHA3 Shows Early MRD Win Read Post »
Clinical TrialsOcular Therapeutix Shows Durable Wet AMD Control With AXPAXLI Ocular Therapeutix Shows Durable Wet AMD Control With AXPAXLI Read Post »
Clinical TrialsAbbVie’s ELAHERE Combo Drives a Targeted Assault on FRα-Positive Tumors AbbVie’s ELAHERE Combo Drives a Targeted Assault on FRα-Positive Tumors Read Post »
Clinical TrialsGSK’s Mo-Rez Breaks Through in BEHOLD-1 With Strong Early Responses GSK’s Mo-Rez Breaks Through in BEHOLD-1 With Strong Early Responses Read Post »
Clinical TrialsKainova Starts Europe Dosing for DT-7012 in DOMISOL Trial Kainova Starts Europe Dosing for DT-7012 in DOMISOL Trial Read Post »
Clinical TrialsCorcept Delivers Survival Benefit With Relacorilant in Phase 3 ROSELLA Corcept Delivers Survival Benefit With Relacorilant in Phase 3 ROSELLA Read Post »
Clinical TrialsBioNTech–DualityBio ADC Delivers Across HER2 Levels in Endometrial Cancer BioNTech–DualityBio ADC Delivers Across HER2 Levels in Endometrial Cancer Read Post »
Clinical TrialsFDA Permits Direct Shift of Ryoncil from IND Stage to Registrational Study FDA Permits Direct Shift of Ryoncil from IND Stage to Registrational Study Read Post »
Clinical TrialsMilestone Opens Real-World Chapter for CARDAMYST With RESET-PSVT Milestone Opens Real-World Chapter for CARDAMYST With RESET-PSVT Read Post »
Clinical TrialsPREVAIL and KOMET Readouts Set Stage for Alexion at AAN 2026 PREVAIL and KOMET Readouts Set Stage for Alexion at AAN 2026 Read Post »
Clinical TrialsVanda Launches Study of NEREUS™ to Reduce Vomiting With GLP-1 Treatments Vanda Launches Study of NEREUS™ to Reduce Vomiting With GLP-1 Treatments Read Post »
Clinical TrialsNew Data Highlight Regenerative Injectables in Menopause, Weight Loss New Data Highlight Regenerative Injectables in Menopause, Weight Loss Read Post »
Clinical Trials Mergers & AcquisitionsBoehringer–BioNTech Partner on ES-SCLC Immunotherapy Trial Boehringer–BioNTech Partner on ES-SCLC Immunotherapy Trial Read Post »
Clinical TrialsPlus Therapeutics Wins FDA Orphan Tag for REYOBIQ Plus Therapeutics Wins FDA Orphan Tag for REYOBIQ Read Post »
Clinical TrialsShionogi Presents Real-World CIRCE Data for Cefiderocol Shionogi Presents Real-World CIRCE Data for Cefiderocol Read Post »
Clinical TrialsInsmed Halts Brensocatib HS Program After Phase 2b Failure Insmed Halts Brensocatib HS Program After Phase 2b Failure Read Post »
Clinical TrialsCatalYm Starts Phase 2b Visugromab Trial in Second-Line HCC CatalYm Starts Phase 2b Visugromab Trial in Second-Line HCC Read Post »
Clinical TrialsNervGen Aligns with FDA on Phase 3 RESTORE Trial of NVG-291 in Chronic Tetr... NervGen Aligns with FDA on Phase 3 RESTORE Trial of NVG-291 in Chronic Tetr... Read Post »
Clinical TrialsSanofi’s Lunsekimig Delivers in Asthma and CRSwNP, Misses Dermatitis Endp... Sanofi’s Lunsekimig Delivers in Asthma and CRSwNP, Misses Dermatitis Endp... Read Post »
Clinical TrialsClimb Bio’s Budoprutug Earns Fast Track Status for pMN Climb Bio’s Budoprutug Earns Fast Track Status for pMN Read Post »
Clinical TrialsTelix Highlights Pipeline Progress, Targets Multiple Regulatory Milestones ... Telix Highlights Pipeline Progress, Targets Multiple Regulatory Milestones ... Read Post »
Clinical Trials Disease & DrugsAmgen Reports Positive Phase 3 Data for Subcutaneous TEPEZZA OBI Amgen Reports Positive Phase 3 Data for Subcutaneous TEPEZZA OBI Read Post »
Clinical TrialsPraxis Reports 77% Seizure Reduction with Elsunersen in Early-Seizure Onset... Praxis Reports 77% Seizure Reduction with Elsunersen in Early-Seizure Onset... Read Post »
Clinical TrialsRisto-cel Demonstrates Consistent Efficacy and Safety in Sickle Cell Diseas... Risto-cel Demonstrates Consistent Efficacy and Safety in Sickle Cell Diseas... Read Post »
Clinical TrialsPriovant Expands Brepocitinib Development Program with Initiation of Phase ... Priovant Expands Brepocitinib Development Program with Initiation of Phase ... Read Post »
Clinical TrialsBridgeBio Reports 54-Month Data, Sustained Survival Benefit with Acoramidis... BridgeBio Reports 54-Month Data, Sustained Survival Benefit with Acoramidis... Read Post »
Clinical TrialsImfinzi – Imjudo Regimen Moves Earlier in HCC with EMERALD-3 Data Imfinzi – Imjudo Regimen Moves Earlier in HCC with EMERALD-3 Data Read Post »
Clinical TrialsInnovent, Ollin Report 20-Week JADE Data Showing OLN324 Durability Edge Ove... Innovent, Ollin Report 20-Week JADE Data Showing OLN324 Durability Edge Ove... Read Post »
Clinical TrialsNovo Nordisk’s Indirect Comparison Data from ORION Puts Wegovy Pill and F... Novo Nordisk’s Indirect Comparison Data from ORION Puts Wegovy Pill and F... Read Post »
Clinical TrialsInnovent’s Mazdutide 9 mg Shows Up to 18.6% Weight Loss in Phase 2 Obesit... Innovent’s Mazdutide 9 mg Shows Up to 18.6% Weight Loss in Phase 2 Obesit... Read Post »
Clinical TrialsPepGen Highlights Promising Safety and Splicing Trends in Phase 2 DM1 Study PepGen Highlights Promising Safety and Splicing Trends in Phase 2 DM1 Study Read Post »
Clinical TrialsOcugen Completes GARDian3 Dosing for OCU410ST in Stargardt Disease Ocugen Completes GARDian3 Dosing for OCU410ST in Stargardt Disease Read Post »
Clinical TrialsAstra Zeneca’s Efzimfotase Alfa Shows Phase III Benefit in HPP, With Mixe... Astra Zeneca’s Efzimfotase Alfa Shows Phase III Benefit in HPP, With Mixe... Read Post »
Clinical TrialsConnect’s Rademikibart Shows Rapid, Sustained FEV1 Improvement Connect’s Rademikibart Shows Rapid, Sustained FEV1 Improvement Read Post »
Clinical TrialsUnited Therapeutics’ Tyvaso Surpasses TETON-2 with Strong TETON-1 IPF Res... United Therapeutics’ Tyvaso Surpasses TETON-2 with Strong TETON-1 IPF Res... Read Post »
Clinical TrialsMerck’s Oral PCSK9 Candidate Enlicitide Cuts LDL-C by 64.6% in Phase 3 Ad... Merck’s Oral PCSK9 Candidate Enlicitide Cuts LDL-C by 64.6% in Phase 3 Ad... Read Post »
Clinical TrialsTanabe’s Dersimelagon Improves Sunlight Tolerance in Phase 3 Study in Rar... Tanabe’s Dersimelagon Improves Sunlight Tolerance in Phase 3 Study in Rar... Read Post »
Clinical TrialsWith 3-Dose Regimen, Viridian’s Elegrobart Shows Breakthrough Potential i... With 3-Dose Regimen, Viridian’s Elegrobart Shows Breakthrough Potential i... Read Post »
Clinical TrialsConnect Biopharma Joins AAD Wave with Strong Phase 3 Rademikibart Data in A... Connect Biopharma Joins AAD Wave with Strong Phase 3 Rademikibart Data in A... Read Post »
Clinical TrialsBeyond Adults: Idorsia’s Daridorexant Shows Promise in Pediatric Insomnia Beyond Adults: Idorsia’s Daridorexant Shows Promise in Pediatric Insomnia Read Post »
Clinical TrialsBMS Reports Stable Cobenfy Switch Data and Positive Phase 3 Camzyos Results... BMS Reports Stable Cobenfy Switch Data and Positive Phase 3 Camzyos Results... Read Post »
Clinical TrialsBiogen’s Litifilimab Shows Phase 2 AMETHYST Success in Cutaneous Lupus Biogen’s Litifilimab Shows Phase 2 AMETHYST Success in Cutaneous Lupus Read Post »
Clinical TrialsTakeda’s Oral TYK2 Inhibitor Zasocitinib Delivers Strong Phase 3 Results ... Takeda’s Oral TYK2 Inhibitor Zasocitinib Delivers Strong Phase 3 Results ... Read Post »
